We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-3.04%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
–
AUM
$2.1B
AUM Growth
+$282M
Cap. Flow
+$321M
Cap. Flow %
15.28%
Top 10 Hldgs %
31.03%
Holding
185
New
43
Increased
48
Reduced
68
Closed
26

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$37.3M
2
SON icon
Sonoco
SON
+$27.1M
3
MTCH icon
Match Group
MTCH
+$24.8M
4
PLD icon
Prologis
PLD
+$23.9M
5
SLB icon
SLB Ltd
SLB
+$19.3M

Top Sells

Rank Stock Value
1
MTB icon
M&T Bank
MTB
+$36.8M
2
ZM icon
Zoom
ZM
+$25.3M
3
WBD icon
Warner Bros
WBD
+$23.6M
4
LYFT icon
Lyft
LYFT
+$22.3M
5
EXPE icon
Expedia Group
EXPE
+$20.5M

Sector Composition

Rank Sector Weight
1 Technology 18.46%
2 Consumer Discretionary 13.65%
3 Healthcare 10.33%
4 Communication Services 7.49%
5 Consumer Staples 7.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IPGP icon
126
IPG Photonics
IPGP
$3.61B
$3.62M 0.17%
49,805
+28,029
+129% +$2.15M
NAK
127
Northern Dynasty Minerals
NAK
$953M
$3.35M 0.16%
5,754,834
-1,242,895
-18% -$554K
CFG icon
128
PUT
Citizens Financial Group
CFG
$30.6B
$3.28M 0.16%
+75,000
New +$3.32M
UFI icon
129
UNIFI
UFI
$129M
$3.21M 0.15%
513,014
-59,675
-10% -$365K
UNIT
130
Uniti Group
UNIT
$2.28B
$3.18M 0.15%
+578,903
New +$3.29M
EMN icon
131
Eastman Chemical
EMN
$8.39B
$3.18M 0.15%
34,788
-9,562
-22% -$981K
AVD icon
132
American Vanguard Corp
AVD
$65.5M
$2.98M 0.14%
643,092
-69,304
-10% -$375K
HURC icon
133
Hurco Companies Inc
HURC
$141M
$2.89M 0.14%
149,857
-17,031
-10% -$358K
TBI
134
Trueblue
TBI
$323M
$2.87M 0.14%
341,383
+106,736
+45% +$824K
SMP icon
135
Standard Motor Products
SMP
$885M
$2.81M 0.13%
90,844
-14,537
-14% -$468K
NGVT icon
136
Ingevity
NGVT
$2.65B
$2.77M 0.13%
+68,059
New +$2.83M
BTG icon
137
B2Gold
BTG
$6.68B
$2.72M 0.13%
1,116,489
+260,645
+30% +$765K
TXG icon
138
10x Genomics
TXG
$7.44B
$2.72M 0.13%
+189,221
New +$2.99M
MG icon
139
Mistras Group
MG
$502M
$2.57M 0.12%
283,509
-31,485
-10% -$310K
CVS icon
140
CVS Health
CVS
$122B
$2.54M 0.12%
+56,578
New +$3.17M
FORR icon
141
Forrester Research
FORR
$221M
$2.53M 0.12%
+161,594
New +$2.6M
PERI icon
142
Perion Network
PERI
$386M
$2.51M 0.12%
295,808
-45,635
-13% -$383K
EAF icon
143
GrafTech
EAF
$205M
$2.48M 0.12%
143,441
-22,587
-14% -$421K
MLKN icon
144
MillerKnoll
MLKN
$1.64B
$2.2M 0.1%
+97,458
New +$2.35M
TROX icon
145
Tronox
TROX
$993M
$2.11M 0.1%
+209,858
New +$2.55M
DOLE icon
146
Dole
DOLE
$1.24B
$2.11M 0.1%
+155,841
New +$2.39M
SEE
147
DELISTED
Sealed Air
SEE
$2.03M 0.1%
59,953
-9,444
-14% -$337K
BILL icon
148
BILL Holdings
BILL
$4.91B
$1.93M 0.09%
22,798
-264,447
-92% -$19.7M
FL
149
DELISTED
Foot Locker
FL
$1.85M 0.09%
+85,023
New +$1.99M
CADE
150
PUT
DELISTED
Cadence Bank
CADE
$1.72M 0.08%
+50,000
New +$1.76M
4 5
6
7 8

Similar funds

SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
ORCP
One Rock Capital Partners New York $2.19B AUM
ET
Entropy Technologies New York $2.17B AUM 21.46% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
MIAS
Mason Investment Advisory Services Reston, Virginia $2.17B AUM 28.39% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
IIP
Intermede Investment Partners London, United Kingdom $2.16B AUM 18.47% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return

Invenomic Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Invenomic Capital Management held 185 positions worth $2.1B, up 15% from $1.82B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Invenomic Capital Management deployed $321M of net new capital in Q4 2024, opening 43 new positions and adding to 48 existing holdings. Its largest new stake was Prologis: 207,979 shares worth $22M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was M&T Bank, an estimated $36.8M trimmed.

  • Invenomic Capital Management's largest Q4 2024 buy was Prologis: 207,979 shares worth $22M.
  • Invenomic Capital Management added most to Dentsply Sirona in Q4 2024, an estimated $37.3M increase.
  • Invenomic Capital Management's biggest Q4 2024 reduction was M&T Bank, cutting an estimated $36.8M.
  • Invenomic Capital Management fully exited Warner Bros in Q4 2024, selling an estimated $23.6M.
  • Invenomic Capital Management's ten largest holdings make up 31% of its $2.1B portfolio in Q4 2024.
  • Invenomic Capital Management opened 43 new positions and closed 26 in Q4 2024.
  • Invenomic Capital Management's portfolio value rose 15% quarter-over-quarter to $2.1B.

Based on Invenomic Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.